Paired inhibitory and activating receptor signals

Reviews in Immunogenetics

Volumn 2, Issue 2, 2000, Pages 204-219

  Taylor, L S ^a   Paul, S P ^a   McVicar, D W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ILT; KIR; Ly49; NKG2; PIR; SHP 1; Signal transduction; Tyrosine phosphorylation

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOPLASMIC RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN RECEPTOR; LECTIN RECEPTOR; MACROPHAGE ACTIVATING FACTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

BINDING AFFINITY; BINDING SITE; BIOCHEMISTRY; CELL ACTIVATION; CELL MEMBRANE POTENTIAL; CELLULAR IMMUNITY; HUMAN; INHIBITION KINETICS; MEDIATOR RELEASE; NATURAL KILLER CELL; PHOSPHORYLATION; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; B-LYMPHOCYTES; HUMAN; KILLER CELLS; MAST CELLS; PROTEIN-TYROSINE KINASE; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0033777148     PISSN: 13981714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Fc receptors
2. Fc receptors
3. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes
4. A 13-amino acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signaling
5. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1
6. Inhibitory MHC class I receptors on NK and T cells: A standard nomenclature
7. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
8. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
9. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4
10. NK cell receptors
11. Killer cell inhibitory receptors: Diversity, specificity, and function
12. Murine NK receptors: Ly-49 expression, function, and intracellular signaling
13. Ly49 gene expression in different inbred mouse strains
14. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor
15. The Ly-49 family: Genes, proteins, and recognition of class I MHC
16. Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48
17. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs
18. Function of killer cell inhibitory receptors for MHC class I molecules
19. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase
20. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation
21. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors
22. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases
23. Differential association of phosphatases with hematopoietic coreceptors bearing immunoreceptor tyrosine-based inhibition motifs
24. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases
25. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling
26. A novel phosphotyrosine motif with a critical amino acid at position -2 for the SH2 domain-mediated activation of the tyrosine phosphatase SHP-1
27. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors
28. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2
29. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C
30. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase
31. Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2
32. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: A new function for Src homology 2 domains
33. Crystal structure of the tyrosine phosphatase SHP-2
34. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc-gamma RIIB
35. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells
36. LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation
37. Molecular cloning of the cDNA encoding pp36, a tyrosine-phosphorylated adaptor protein selectively expressed by T cells and natural killer cells
38. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors
39. NK cytokine secretion and cytotoxicity occur independently of the SLP-76 adaptor protein
40. Essential role of LAT in T cell development
41. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
42. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p561ck kinase
43. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells
44. The Ly-49D receptor activates murine natural killer cells
45. Ly49D and Ly49H associate with mouse DAP12 and form activating receptors
46. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H
47. Cloning and characterization of a novel activating Ly49 closely related to Ly49A
48. Major histocompatibility complex class I specific receptors on human natural killer and T lymphocytes
49. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts
50. Cutting edge: Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly49D signal transduction
51. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
52. Signaling through human killer cell activating receptors triggers tyrosine phosphorylation of an associated protein complex
53. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
54. Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum
55. Membrane protein association by potential intramembrane charge pairs
56. ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery
57. Of ITAMs and ITIMs: Turning on and off the B cell antigen receptor
58. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor
59. DAP12 mediated signal transduction in NK cells: A dominant role for the Syk protein tyrosine kinase
60. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction
61. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases
62. Differential activation of the tyrosine kinases ZAP-70 and Syk after Fc gamma RI stimulation
63. The product of the proto-oncogene c-cbl: A negative regulator of the Syk tyrosine kinase
64. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells
65. The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70
66. Natural killer activating receptors trigger interferon g secretion from T cells and natural killer cells
67. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors
68. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity
69. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing
70. Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase
71. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex
72. NK cell mediated recognition of HLA class Ib molecules: Role of CD94/NKG2 receptors
73. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E
74. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: Evidence for receptor function in heterologous transfectants
75. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
76. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
77. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses
78. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells
79. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR + T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody
80. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody
81. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands
82. Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen
83. Association of DAP12 with activating CD94/NKG2C NK cell receptors
84. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
85. An activating immunoreceptor complex formed by NKG2D and DAP10
86. Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
87. CD28: A signalling perspective
88. SH2 domains recognize specific phosphopeptide sequences
89. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav
90. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
91. Receptor-induced death in human natural killer cells: Involvement of CD16
92. Activation-induced NK cell death triggered by CD2 stimulation
93. CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells
94. NK cells and apoptosis
95. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis
96. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells
97. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells
98. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells
99. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
100. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
101. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
102. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
103. A new human gene complex encodes the killer cell inhibitory receptors and a related family of monocyte/macrophage receptors
104. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
105. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
106. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes
107. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes
108. The leukocyte immunoglobulin-like receptors (LIRs): A new family of immune regulators
109. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain
110. Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors
111. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells
112. Paired immunoglobulin-like receptors of activating and inhibitory types
113. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family
114. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal
115. Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1
116. Inhibitory and stimulatory functions of paired Ig-like receptor (PIR) family in RBL-2H3 cells
117. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1
118. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B
119. Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages
120. 632 of paired immunoglobulin receptor (PIR)-A3 in murine macrophages
121. Stimulatory function of paired immunoglobulin-like receptor-A in mast cell line by associating with subunits common to Fc receptors
122. Paired immunoglobulin-like receptor (PIR)-A is involved in activating mast cells through its association with Fc receptor γ chain
123. BIT, an immune antigen receptor-like molecule in the brain
124. A family of proteins that inhibit signalling through tyrosine kinase receptors
125. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages
126. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells
127. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling
128. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2
129. Cutting edge: Signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells
130. A newly recognized pathway for the negative regulation of mast cell-dependent hypersensitivity and inflammation mediated by an endogenous cell surface receptor of the gp49 family
131. The gp49A gene has extensive sequence conservation with the gp49B gene and provides gp49A protein, a unique member of a large family of activating and inhibitory receptors of the immunoglobulin superfamily
132. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE
133. Gene structure of the murine NK cell receptor 2B4: Presence of two alternatively spliced isoforms with distinct cytoplasmic domains
134. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4
135. Myeloid specific human CD33 is an inhibitory receptor whose ITIMs function differently in recruiting the phosphatases SHP-1 and SHP-2
136. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2
137. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor
138. Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigen
139. Sialic acid binding receptors (siglecs) expressed by macrophages
140. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
141. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
142. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors